Portfolio company
Humeltis
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops three-dimensional lung tissue models for pharmaceutical research, toxicology testing and personalised medicine for biotechnology and healthcare organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Hooke Bio
This company develops a microfluidic platform using three-dimensional human tissue models for preclinical drug testing for pharmaceutical and biotechnology organisations.
Invitrolize
This company develops in vitro lung models to identify respiratory hazards for pharmaceutical, cosmetic, chemical and consumer goods organisations.
HumGel
The company produces human tumor-derived hydrogels for researchers and pharmaceutical innovators to use in 3D cell culture and drug testing.
Organo-ID
The company develops 3D organoid models and drug response tests for cancer patients and pharmaceutical researchers to improve personalised medicine and treatment efficacy.
Prometheus Life Technologies
The company produces human tissue organoids in microgravity for pharmaceutical researchers to improve drug development, testing and regenerative medicine.
Stemnovate
This company develops human cell-based platforms for drug discovery and toxicity testing to support pharmaceutical firms and research institutions.
Cellink
This company develops 3D bioprinters and bioinks for researchers in academic, pharmaceutical and industrial laboratories to create human tissue models and organs.
Tessel Biosciences
The company develops artificial intelligence models and patient-derived virtual tissues to accelerate drug discovery for pharmaceutical and biotechnology organisations.
